Nobuhisa Nakamura

Physical fitness Its contribution to serum high density lipoprotein

The effects of exercise conditioning on serum high density lipoprotein cholesterol (HDL-C) were studied using 20 members of a regular joggers club and other healthy non-member subjects of varying degrees of habitual physical activity (253 males and 391 females). Both the HDL-C and HDL-C/serum total cholesterol (TC) levels were significantly higher with the 20 regular joggers than with the sedentary controls matched for age, TC, serum triglycerides (TG) and weight index (WI). A significant correlation was found between HDL-C/TC and the exercise conditioning value obtained by using the results of the 12-min performance test as an index among the non-member subjects. In order to ascertain the relative significance of exercise conditioning in influencing HDL-C/TC, a multiple regression analysis was conducted using HDL-C/TC as the variable criterion. The results showed that TG affected HDL-C/TC the most among both males and females, while exercise conditioning affected it second among males and fourth among females.

Increased platelet phospholipase activity in diabetic subjects

We studied platelet phospholipase activity in 35 diabetes mellitus (DM) patients and 27 age-matched controls. In the diabetics, the mean activity was 9.73±0.54 n mol/mg prot/30 sec, significantly higher (p<0.005) than in the controls (7.80±0.43). The degree of phospholipase was not significantly different between insulin-dependent and noninsulin-dependent diabetics, and between patients treated or not with insulin. DM patients with complications manifested the highest activity (11.45±1.16,n=14, p<0.005). The addition of platelet-poor plasma (PPP) to autologous 14C-arachidonate-labeled platelet suspensions generally lowered the phospholipase level. In the presence of PPP, phospholipase values were higher in diabetics with complications (p<0.05); overall, the DM values were not significantly different from the controls. Dietary therapy decreased serum lipids but not phospholipase; the reverse applied upon insulin or glibenclamide treatment. A dose-dependent decrease of phospholipase by in vitro insulin addition was observed only in diabetics; glucose had no effect on phospholipase of control platelets. The mechanism of increased phospholipase activity observed in DM is discussed.

Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan

Apolipoprotein (apo) E phenotype was examined in 188 healthy subjects and in 447 patients seen between 1984 and 1986. The frequency of the apo E2, 3, and 4 genes in the clinically healthy subjects was 0.035 +/- 0.0288, 0.872 +/- 0.0310, and 0.093 +/- 0.0152, respectively. The frequency of the apo E3 gene was higher and that of the apo E genes 2 and 4 lower than that reported in western countries. Clinical features and apo E phenotype are presented from the 5 patients with type III hyperlipoproteinemia (HLP) due to apo E phenotype E2/2 (E2-III); all patients in E2-III were post-menopausal women. In contrast to the clinical characteristics so far reported, no notable findings of atherosclerosis, such as coronary angiographic findings or xanthoma, were evident in any of these 5 patients. Glucose intolerance was seen in 4 of them. Four patients were normolipidemic with apo E phenotype E2/2 (E2-N). In addition, plasma lipid and apolipoprotein concentrations were determined in patients with different apo E phenotypes. Plasma total cholesterol (TC) and apo B levels were elevated in the order of E2-N, E2/3, E2/4, E3/3, E3/4 and E4/4 except for E2-III. The plasma apo E level was highest in E2-III but was not significantly different from other phenotypes. The apo B/apo E and apo C-III/apo E ratios were significantly lower in E2/2 than in other phenotypes. The TC/apo B ratio was significantly higher in E2/2 than in other phenotypes.

Polymorphisms of apolipoprotein C-III in two cases with sialidase deficiency

Abstract Since sialidase is thought to be one of the enzymes which are concerned with the polymorphic forms of apolipoprotein C-III depending on the contents of terminal sialic acid, the polymorphic forms of apolipoprotein C-III of very low density lipoprotein and apolipoprotein C-III levels were studied in two cases of sialidosis due to sialidase deficiency with or without β-galactosidase deficiency. The diagnosis was established by the defect of those enzymes in the leucocytes and cultured fibroblasts. But, no significant differences in polymorphic form of apolipoprotein C-III were observed between these two patients and controls.